Disturbed structural connectivity in schizophrenia - Primary factor in pathology or epiphenomenon?

Schizophrenia Bulletin

Volumn 34, Issue 1, 2008, Pages 72-92

  Konrad, Andreas ^a   Winterer, Georg ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Myelination; Neuregulin; Oligodendrocytes; Postmortem

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MYELIN; NEU DIFFERENTIATION FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANISOTROPY; APOPTOSIS; AUTOPSY; BRAIN CELL; BRAIN TISSUE; CORTICAL SYNCHRONIZATION; DEMYELINATING DISEASE; DIFFUSION TENSOR IMAGING; ELECTROMAGNETIC FIELD; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; METACHROMATIC LEUKODYSTROPHY; MORPHOMETRICS; MYELIN SHEATH; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROIMAGING; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIA; PATHOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; ULTRASTRUCTURE;

DIFFUSION MAGNETIC RESONANCE IMAGING; GENES, ERBB; HUMANS; MAGNETIC RESONANCE IMAGING; MYELIN SHEATH; NERVE FIBERS; NERVE NET; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; SCHIZOPHRENIA;

EID: 37149001493     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm034     Document Type: Review

References (165)

1. Weinberger DR, Egan MF, Bertolino A, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 2001;50:825-844.
2. Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol. 1990;28:597-561.
3. McIntosh AR. Mapping cognition to the brain through neural interactions. Memory. 1999;7:523-548.
4. Hoffman RE, Buchsbaum MS, Escobar MD, Makuch RW, Nuechterlein KH, Guich SM. EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation. J Neuropsychiatry Clin Neurosci. 1991;3:169-175.
5. Weinberger DR. A connectionist approach to the prefrontal cortex. J Neuropsychiatry Clin Neurosci. 1993;5:241-253.
6. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci. 1995;3:89-97.
7. Bullmore ET, Frangou S, Murray RM. The dysplastic net hypothesis: an integration of developmental and disconnectivity theories of schizophrenia. Schizophr Res. 1997;28:143-156.
8. Fletcher P, McKenna PJ, Friston KJ, Frith CD, Dolan RJ. Abnormal cingulate modulation of fronto-temporal connectivty in schizophrenia. Neuroimage. 1999;9:337-342.
9. Meyer-Lindenberg A, Poline JP, Kohn PD, et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry. 2001;158: 1809-1817.
10. Winterer G, Egan MF, Rädler T, Hyde T, Coppola R, Weinberger DR. An association between reduced interhemispheric EEG coherence in the temporal lobe area and genetic risk for schizophrenia. Schizophr Res. 2001;49:129-143.
11. Winterer G, Coppola R, Egan MF, Goldberg TE, Weinberger DR. Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biol Psychiatry. 2003;54:1181-1192.
12. Schlösser R, Gesierich T, Kaufmann B, et al. Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling. Neuroimage. 2003;19:751-763.
13. Schlösser R, Gesierich T, Kaufmann B, Vucurevic G, Stoeter P. Altered effective connectivity in drug free schizophrenic patients. Neuroreport. 2003;14:2233-2237.
14. Stephan KE, Baldeweg T, Friston KJ. Synaptic Plasticity and Dysconnection in Schizophrenia. Biol Psychiatry. 2006; 59:929-939.
15. Foong J, Maier M, Barker GJ, Brocklehurst S, Miller DH, Ron MA. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry. 2000;68:70-74.
16. Foong J, Symms MR, Barker GJ, Maier M, Miller DH, Ron MA. Investigating regional white matter in schizophrenia using diffusion tensor imaging. Neuroreport. 2002;13: 333-336.
17. Burns J, Job D, Bastin ME, et al. Structural disconnectivity in schizophrenia: a diffusion tensor magentic resonance imaging study. Br J Psychiatry. 2003;182:439-443.
18. Bagary MS, Symms MR, Barker GJ, Mutsatsa SH, Joyce EM, Ron MA. Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Arch Gen Psychiatry. 2003;60:779-788.
19. Kubicki M, Westin CF, Nestor PG, et al. Cingulate fasciculus integrity disruption in schizophrenia: a magentic resonance diffusion tensor imaging study. Biol Psychiatry. 2003;54:1171-1180.
20. Kubicki M, Park H, Westin CF, et al. DTI and MTI abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage. 2005;26:1109-1118.
21. Kubicki M, McCarley R, Westin CF, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41:15-30.
22. Kalus P, Slotboom J, Gallinat J, et al. The amygdala in schizophrenia: a trimodal magnetic resonance imaging study. Neurosci Lett. 2005;375:151-156.
23. Uranova NA, Casanova MF, DeVaughn NM, Orlovskaya DD, Denisov DV. Ultrastructural pathology of neuronal connectivity in postmortem brains of schizophrenic patients. Schizophr Res. 1996;22:81-83.
24. Uranova NA, Orlovskaya DD, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597-610.
25. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dyregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 2001;98: 4746-4751.
26. Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798-805.
27. Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 2004;77:858-866.
28. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry. 2006;60:132-140.
29. Volkow ND, Wolf AP, Brodie JD, et al. Brain interactions in chronic schizophrenics under resting and activation conditions. Schizophr Res. 1988;1:47-53.
30. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant twins. Am J Psychiatry. 1992;149:890-897.
31. Frith CD, Friston KJ, Herold S, et al. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry. 1995; 167:343-349.
32. Andreasen NC, O'Leary DS, Flaum M, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997;349:1730-1734.
33. Fletcher P, McKenna PJ, Friston KJ, Frith CD, Dolan RJ. Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia. Neuroimage. 1999;9:337-342.
34. Spence SA, Liddle PF, Stefan MD, et al. Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed connectivity reappraised. Br J Psychiatry. 2000;176:52-60.
35. Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry. 2002;51:1008-1011.
36. Ragland JD, Gur RC, Valdez J, et al. Event-related fMRI of frontotemporal activity during world encoding and recognition in schizophrenia. Am J Psychiatry. 2004;161:1004-1015.
37. Frecska E, Symer C, White K, Piscani K, Kulcsar Z. Preceptional and executive deficits of chronic schizophrenic patients in attentional and intentional tasks. Psychiatry Res. 2004;126:63-75.
38. Tauscher J, Fischer P, Neumeister A, Rappelsberger P, Kasper S. Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients. Biol Psychiatry. 1998;44:438-447.
39. Mann K, Maier W, Franke P, Roschke J, Gansicke M. Intra- and interhemispheric electroencephalogram coherence in siblings discordant for schizophrenia and healthy volunteers. Biol Psychiatry. 1997;42:655-663.
40. Whalley HC, Simonotto E, Marshall I, et al. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain. 2005;28:2097-2108.
41. Cannon TD, van Erp TGM, Huttunen M, et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 1998;55:1084-1091.
42. Tamagaki C, Sedvall GC, Jonsson EG, et al. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric study. Am J Psychiatry. 2005;162:2315-2321.
43. Winterer G, Hariri AR, Goldman D, Weinberger DR. Neuroimaging and human genetics. Int Rev Neurobiol. 2005;67: 325-383.
44. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16-25.
45. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1-52.
46. Sigmundsson T, Suckling J, Maier M, et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry. 2001;158:234-243.
47. Paillere-Martinot M, Caclin A, Artiges E, et al. Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr Res. 2001;50:19-26.
48. Okugawa G, Sedvall GC, Agartz I. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2002;252:120-123.
49. Cahn W, Hulshoff Pol HE, Bongers M. Brain morphology in antipsychotic-naive schizophrenia: a study of multiple brain structures. Br J Psychiatry. 2002;43:66-72.
50. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60:585-594.
51. Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry. 2003;53:412-421.
52. Zhou SY, Suzuki M, Hagoni H, et al. Decreased volume and increased asymmetry of the anterior limb of the internal capsure in patients with schizophrenia. Biol Psychiatry. 2003; 54:427-436.
53. Takase K, Tamagaki C, Okugawa G, et al. Reduced white matter volume of the caudate nucleus in patients with schizophrenia. Neuropsychobiology. 2004;50:296-300.
54. Zhou SY, Suzuki M, Hagoni H, et al. Volumetric analysis of sulci/gyri-defined in vivo frontal lobe regions in schizophrenia: precentral gyrus, cingulate gyrus, and prefrontal region. Psychiatry Res Neuroimaging. 2005;139: 127-139.
55. Davatzikos C, Shen D, Gur RC, et al. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry. 2005;62: 1218-1227.
56. Chua SE, Cheung C, Cheung V, et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res. 2007;89:12-21.
57. Ho BC, Andreasen NC, Nopoulos P, et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 2003;60:585-594.
58. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62:361-370.
59. Paillere-Martinot M, Caclin A, Artiges E, et al. Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr Res. 2001; 50:19-26.
60. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 1995;8:333-344.
61. Basser PJ, Pierpaoli C. Toward a quantitative assessment if diffusion anisotropy. Magn Reson Med. 1996;36:893-906.
62. Hüppi PS, Maier SE, Peled S, et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res. 1998;44:584-590.
63. Baratti C, Barnett AS, Pierpaoli C. Comparative MR imaging study of brain maturation in kittens with T1, T2, and the trace of the diffusion tensor. Radiology. 1999;210:133-142.
64. Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology. 2001;56:304-311.
65. Papadakis NG, Xing D, Houston GC, et al. A study of rotationally invariant and symmetric indices of diffusion anisotropy. Magn Reson Imaging. 1999;17:881-892.
66. Hong YH, Lee KW, Sung JJ, Chang KH, Song C. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci. 2004;227:73-78.
67. Toosy AT, Werring DJ, Orrell RW, et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2003;74:1250-1257.
68. Koester J, Siegelbaum SA. Local signaling: passive electrical properties of the neuron. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principle of Neural Science. ;New York, NY McGraw-Hill, 4th ed; 140-149.
69. Winterer G, Carver FW, Musso F, Mattay V, Weinberger DR, Coppola R. Complex relationship between BOLD signal and synchronisation/desynchronisation of human brain MEG oscillations. Hum Brain Mapp. 2006;doi:10.1002/hbm. 20322.
70. Winterer G, Ziller M, Dorn H, et al. Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin Neurophysiol. 2000;111:837-849.
71. Winterer G, Coppola R, Goldberg TE, et al. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. Am J Psychiatry. 2004;161:490-500.
72. Winterer G, Musso F, Beckmann C, et al. Instability of prefrontal signal processing in schizophrenia. Am J Psychiatry. 2006;163:1960-1968.
73. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 2004;27:683-690.
74. Kanaan RAA, Kim JS, Kaufmann WE, Pearlson GD, Barker GJ, McGuire PK. Diffusion tensor imaging in schizophrenia. Biol Psychiatry. 2005;58:921-929.
75. Buchsbaum MS, Tang CY, Peled S, et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 1998;9:425-430.
76. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry. 2000;68:242-244.
77. Agartz I, Andersson JLR, Skare S. Abnormal brain white matter in schizophrenia: a diffusion tensor imaging study. Neuroreport. 2001;12:2251-2254.
78. Steel RM, Bastin ME, McConnell S, et al. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res. 2001;106:161-170.
79. Hoptman MJ, Volavka J, Johnson G, Weiss E, Bilder RM, Lim KO. Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol Psychiatry. 2002;52:9-14.
80. Kubicki M, Westin CF, Maier SE, et al. Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry. 2002;159:813-820.
81. Sun Z, Wang F, Cui L, et al. Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study. Neuroreport. 2003;14:1833-1836.
82. Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 2003;14:2025-2029.
83. Wolkin A, Choi SJ, Szilagyi S, Sanfilipo M, Rotrosen JP, Lim KO. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am J Psychiatry. 2003;160:572-574.
84. Wang F, Sun Z, Du X, et al. A diffusion tensor imaging study of middle and superior cerebellar peduncle in male patients with schizophrenia. Neurosci Lett. 2003;348:135-138.
85. Begre S, Federspiel A, Kiefer C, Schroth G, Dierks T, Strik WK. Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia. Neuroreport. 2003;14: 739-742.
86. Okugawa G, Nobuhara K, Minami T, et al. Subtle disruption of the middle cerebellar peduncles in patients with schizophrenia. Neuropsychobiology. 2004;50:119-123.
87. Wang F, Sun Z, Cui L, et al. Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. Am J Psychiatry. 2004;161:573-575.
88. Kumra S, Ashtari M, McMeniman M, et al. Reduced frontal white matter integrity in early-onset schizophrenia: a preliminary study. Biol Psychiatry. 2004;55:1138-1145.
89. Kalus P, Buri C, Slotboom J, et al. Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia. Neuroreport. 2004;15:867-871.
90. Hubl D, Koenig T, Strik W, et al. Pathways that make voices, white matter changes in auditory hallucinations. Arch Gen Psychiatry. 2004;61:658-668.
91. Price G, Bagary MS, Cercignani M, Altmann DR, Ron MA. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry. 2005;76:585-587.
92. Szeszko PR, Ardekani BA, Ashtari M, et al. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry. 2005;162:602-605.
93. Karuoki N, Kubicki M, Nestor PG. Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry. 2006;60:22-31.
94. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 1999;56:367-374.
95. Minami T, Nobuhara K, Okugawa G, et al. Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology. 2003;47:141-145.
96. Jones DK, Catani M, Pierpaoli C, et al. Age effects on diffusion tensor magnetic resonance tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp. 2006;27:230-238.
97. Salat DH, Tuch DS, Greve DN, et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging. 2005;26:1215-1227.
98. Pfefferbaum A, Adalsteinsson E, Sullivan EV. Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage. 2005;26:891-899.
99. Begre S, Federspiel A, Kiefer C, Schroth G, Dierks T, Strik WK. Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia. Neuroreport. 2003;14: 739-742.
100. Price G, Bagary MS, Cercignani M, Altmann DR, Ron MA. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry. 2005;76:585-587.
101. Hao Y, Liu Z, Jiang T, et al. White matter integrity of the whole brain is disrupted in first-episode schizophrenia. Neuroreport. 2006;17:23-26.
102. Tan HY, Choo WC, Fones CS, Chee MW. FMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia. Am J Psychiatry. 2005;162:1783-1784.
103. Snitz BE, MacDonald AIII, Cohen JD, Cho RY, Becker T, Carter CS. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry. 2005;162:2322-2329.
104. Stehen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry. 2006;188:510-518.
105. Molina V, Sanz J, Sarramea F, Luque R, Benito C, Palomo T. Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2006; 256:106-111.
106. Kubicki M, McCarley RW, Shenton ME. Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry. 2005;18:121-134.
107. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31:1487-1505.
108. Jones DK, Symms MR, Cercignani M, Howard RJ. The effect of filter size on VBM analyses of DT-MRI data. Neuroimage. 2005;26:546-554.
109. Foong J, Symms MR, Barker GJ, et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain. 2001;124:882-892.
110. McLean MA, Simister RJ, Barker GJ, Duncan JS. Magnetization transfer effect on human brain metabolites and macromolecules. Magn Reson Med. 2005;54:1281-1285.
111. Davies GR, Ramani A, Dalton CM, et al. Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin? Mult Scler. 2003;9:246-249.
112. European Federation of Neurological Societies Task Force. The future of megnetic resonance-based techniques in neurology. 2001;17-25.
113. Bagary MS, Foong J, Maier M, et al. A magnetization transfer analysis of the thalamus in schizophrenia. J Neuropsychiatry Clin Neurosci. 2002;14:443-448.
114. Kiefer C, Slotboom J, Buri C, et al. Differentiating hippocampal subregions by means of quantitative magnetization transfer and relaxometry: preliminary results. Neuroimage. 2004;23:1093-1099.
115. Berger GE, Wood SJ, Pantelis C, Velakoulis D, Wellard RM, McGorry PD. Implications of lipid biology for the pathogenesis of schizophrenia. Aust N Z J Psychiatry. 2002;36:355-366.
116. Riehemann S, Volz HP, Smesny S, et al. Phosphorus 31 magnetic resonance spectroscopy in schizophrenia research. Pathophysiology of cerebral metabolism of high-energy phosphate and membrane phospholipids. Nervenarzt. 2000; 71:354-363.
117. Stanley JA, Pettegrew JW, Keshavan MS. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part I. Biol Psychiatry. 2000;48:357-368.
118. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part II. Biol Psychiatry. 2000;48:369-380.
119. Vance AL, Velakoulis D, Maruff P, Wood SJ, Desmond P, Pantelis C. Magnetic resonance spectroscopy and schizophrenia: what have we learnt? Aust N Z J Psychiatry. 2000; 34:14-25.
120. Fukuzako H. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J Biol Psychiatry. 2001;2:70-82.
121. Jensen JE, Al-Semaan YM, Williamson PC, et al. Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia: (31)P-MRS study at 4.0 Tesla. Br J Psychiatry. 2002;180:39-44.
122. Yacubian J, de Castro CC, Ometto M, et al. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res. 2002;58:117-122.
123. Wood SJ, Berger G, Velakoulis D, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr Bull. 2003;29:831-843.
124. Jayakumar PN, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Srinivas JS, Keshavan MS. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biol Psychiatry. 2003;54:491-494.
125. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. Am J Psychiatry. 2004;161:1304-1306.
126. Jensen JE, Miller J, Williamson PC, et al. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry. 2004;186:77-78.
127. Jensen JE, Miller J, Williamson PC, et al. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Psychiatry Res. 2006;146:127-135.
128. Smesny S, Rosburg T, Nenadic I, et al. Metabolic mapping using 2D (31)P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia. Neuroimage. 2007;35:729-737.
129. Jayakumar PN, Venkatasubramanian G, Keshavan MS, Srinivas JS, Gangadhar BN. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naive schizophrenia. Acta Psychiatr Scand. 2006;114:346-351.
130. Reddy R, Keshavan MS. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2003;69:401-405.
131. Schmitt A, Wilczek K, Blennow K, et al. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry. 2004;56:41-45.
132. Alzheimer A. Beitrag zur Kenntnis der pathologischen Neuroglia und ihre Beziehung zu Abbauvorgängen im Nervengewebe. In: Nissl F, Alzheimer A, Hrsg, eds. Histologische und Histopathologische Arbeiten über die Großhirnrinde. Jena, Deutschland: Gustav Fischer; 1910:401-404.
133. Helmstaedt ER. An observation of metachromatic leukodystrophy. Dtsch Z Nervenheilkd0. 1963;184:213-234.
134. Wrobe D, Henseler M, Huettler S, Pascual SI, Chabas A, Sandhoff K. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel ase of metachromatic leukodystrophy (MLD). J Inherit Metab Dis. 2000;23:63-67.
135. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 1992;49: 401-406.
136. Marner L, Pakkenberg B. Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics. J Psychiatr Res. 2003;37:539-547.
137. Uranova NA, Vostrikow VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67:269-275.
138. Hof PR, Haroutunian V, Friedrich VL, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry. 2003;53: 1075-1085.
139. Selemon LD, Mrzljak J, Kleinman JE, Herman MM, Goldman-Rakic PS. Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Brocás area 44 and area 9. Arch Gen Psychiatry. 2003;60: 69-77.
140. Flynn SW, Lang DL, Mackay AL, et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post mortem with analysis of oligodentrocyte proteins. Mol Psychiatry. 2003;8:811-820.
141. Black JE, Kodish IM, Grossman AW, et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry. 2004;161: 742-744.
142. Vostrikov VM, Uranova NA, Rakhmanova VI, Orlovskaya DD. Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakowa. 2004;104:47-51.
143. Schmitt A, Wilczek K, Blennow K, et al. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry. 2004;56:41-45.
144. Davis KL, Haroutunian V. Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:758.
145. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet. 2003;123: 59-64.
146. Davis KL, Stewart DG, Friedman JI, et al. White matter changes in schizophrenia: evidence from myelin-related dysfunction. Arch Gen Psychiatry. 2003;60:443-456.
147. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain. 1999;122:99-110.
148. Arnold SE, Ruscheinsky DD, Han L-Y. Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analysis. Biol Psychiatry. 1997;42:639-647.
149. Eastwood SL, Harrison PJ. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry. 2003;8:821-831.
150. Rioux L, Nissanov J, Lauber K, et al. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am J Psychiatry. 2003;160: 149-155.
151. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in reponse to action potentials. Neuron. 2002;36: 855-868.
152. Glass JD, Fischer LR, Culver DG, et al. Motor neuron disease in the G93A SOD-1 mutant mouse and in sporadic human ALS is a "dying back" axonopathy. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:9-12.
153. Karlsborg M, Rosenbaum S, Wiegell MR, et al. Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:136-140.
154. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71:877-892.
155. Stefansson H, Sarginson J, Kong A, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 2003;72:83-87.
156. Munafo MR, Thiselton DL, Clark TG, Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:539-546.
157. Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci. 2004;7:575-580.
158. Crone SA, Lee KF. Gene targeting reveals multiple essential functions of the neuregulin signaling system during development of the neuroendocrine and nervous systems. Ann N Y Acad Sci. 2002;971:547-553.
159. Garratt AN, Britsch S, Birchmeier C. Neuregulin, a factor with many functions in the life of a schwann cell. Bioessays. 2000;22:987-996.
160. Michailov GV, Sereda MW, Brinkmann BG, et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science. 2004;304:688-689.
161. Taveggia C, Zanazzi G, Petrylak A, et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron. 2005;47:681-694.
162. Yang JZ, Si TM, Ruan Y, et al. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry. 2003;8:706-709.
163. Law AJ, Shannon-Weickert C, Hyde TM, Kleinman JE, Harrison PJ. Neuregulin-1 (NRG-1) mRNA and protein in the adult brain. Neuroscience. 2004;127:125-136.
164. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284:14-30.
165. Meng Y, Zhang Y, Tregoubov V, Falls DL, Jia Z. Regulation of spine morphology and synaptic function by LIMK and the actin cytoskeleton. Rev Neurosci. 2003;14: 233-240.